ArticleHuman vaccines & immunotherapeutics2025
Strategic positioning of immunization at the heart of Africa's health and development agenda.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Immunization is one of the greatest public health achievements of all times, preventing millions of deaths and making major improvements in child survival in Africa. Beyond protecting against infectious diseases, vaccines foster educational attainment, productivity, and poverty reduction, while mitigating antimicrobial resistance and economic shocks. However, each year more than 9.5 million children in the World Health Organization African Region remain under-vaccinated, resulting in recurrent outbreaks of vaccine-preventable diseases. In 2024 alone, 59 outbreaks were reported across the region, including measles, variant polioviruses, meningitis, cholera, and yellow fever. To meet growing demands amid constrained resources, we propose three strategic shifts to reimagine immunization as a catalyst for resilient health systems and equitable development in Africa: (1) transitioning from vertical delivery models to integrated approaches embedded in primary health care; (2) expanding success metrics beyond coverage to include equity, resilience, and process indicators, supported by implementation science and digital innovations; and (3) reframing immunization as a whole-of-society development priority anchored in political leadership, sustainable financing, and regional vaccine manufacturing. By embracing these shifts, Africa can transform immunization into a driver of health system strengthening, equity, and sustainable development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.